atenolol has been researched along with Weight Loss in 11 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We compared the effects of transdermal clonidine and oral atenolol on acute exercise performance and on conditioning response to an 8-week program of regular aerobic exercise in young, otherwise healthy subjects with mild hypertension." | 9.06 | Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension. ( Davidman, M; Davies, SF; Graif, JL; Husebye, DG; Iber, C; Maddy, MM; McArthur, CD; O'Connell, MB; Path, MJ, 1989) |
| " They were randomized to a usual diet (n = 296) or to a weight loss diet (n = 291) and within each diet group to placebo, chlorthalidone, 25 mg/d, or atenolol, 50 mg/d." | 5.07 | Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension. ( Blaufox, MD; Cutler, JA; Davis, BR; Kirchner, K; Langford, HG; Oberman, A; Wassertheil-Smoller, S; Zimbaldi, N, 1993) |
| "Subjects were randomly assigned to usual, weight loss, or low sodium/high potassium diet and then randomly assigned to receive placebo, chlorthalidone, or atenolol." | 5.07 | Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy. ( Blaufox, MD; Davis, B; Langford, H; Lee, HB; Oberman, A; Wassertheil-Smoller, S, 1992) |
| " The Trial of Antihypertensive Interventions and Management studied 878 mildly hypertensive individuals randomly assigned, in a 3 x 3 design, to no diet change, weight loss, or a low sodium-high potassium diet and to placebo, 25 mg chlorthalidone, or 50 mg atenolol." | 5.07 | Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group. ( Blaufox, MD; Cutler, JA; Davis, BR; Hawkins, CM; Langford, HG; Oberman, A; Wassertheil-Smoller, S; Zimbaldi, N, 1992) |
| "We compared the effects of transdermal clonidine and oral atenolol on acute exercise performance and on conditioning response to an 8-week program of regular aerobic exercise in young, otherwise healthy subjects with mild hypertension." | 5.06 | Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension. ( Davidman, M; Davies, SF; Graif, JL; Husebye, DG; Iber, C; Maddy, MM; McArthur, CD; O'Connell, MB; Path, MJ, 1989) |
| "Atenolol treatment reduced REE by 77+/-14 kcal/day and propranolol by 48+/-13 kcal/day, respectively (P<0." | 2.69 | Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients. ( Daneryd, P; Hyltander, A; Körner, U; Lundholm, K; Sandström, R, 2000) |
| "This report examines the effect of weight loss, alone and in combination with drugs, on diastolic blood pressure change in the Trial of Antihypertensive Interventions and Management (TAIM), which is a randomized, multicenter, placebo-controlled clinical trial of drug and diet combinations in the treatment of mild hypertension among 787 patients." | 2.67 | The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. ( Blaufox, MD; Davis, BR; Langford, HG; Oberman, AS; Wassertheil-Smoller, S; Wylie-Rosett, J, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Selen, DJ | 1 |
| Gilbert, MP | 1 |
| El-Haddad, B | 1 |
| Hammoud, D | 1 |
| Shaver, T | 1 |
| Shahouri, S | 1 |
| Blaak, EE | 1 |
| Van Baak, MA | 1 |
| Kemerink, GJ | 1 |
| Pakbiers, MT | 1 |
| Heidendal, GA | 1 |
| Saris, WH | 1 |
| Davis, BR | 3 |
| Blaufox, MD | 5 |
| Oberman, A | 4 |
| Wassertheil-Smoller, S | 5 |
| Zimbaldi, N | 2 |
| Cutler, JA | 2 |
| Kirchner, K | 1 |
| Langford, HG | 3 |
| Hyltander, A | 1 |
| Daneryd, P | 1 |
| Sandström, R | 1 |
| Körner, U | 1 |
| Lundholm, K | 1 |
| Lee, HB | 1 |
| Davis, B | 2 |
| Langford, H | 2 |
| Hawkins, CM | 1 |
| Oberman, AS | 1 |
| Wylie-Rosett, J | 1 |
| Kaplan, NM | 1 |
| Davies, SF | 1 |
| Graif, JL | 1 |
| Husebye, DG | 1 |
| Maddy, MM | 1 |
| McArthur, CD | 1 |
| Path, MJ | 1 |
| O'Connell, MB | 1 |
| Iber, C | 1 |
| Davidman, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000513] | Phase 3 | 0 participants | Interventional | 1984-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 trials available for atenolol and Weight Loss
| Article | Year |
|---|---|
Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Chlorthalidone; Female; Humans; Hypertension; Male; | 1993 |
Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients.
Topics: Adrenergic beta-Antagonists; Atenolol; Cachexia; Calorimetry, Indirect; Carbohydrate Metabolism; Ene | 2000 |
Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy.
Topics: Adult; Aged; Atenolol; Chlorthalidone; Diastole; Humans; Hypertension; Middle Aged; Regression Analy | 1992 |
Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group.
Topics: Atenolol; Chlorthalidone; Combined Modality Therapy; Energy Intake; Exercise; Female; Humans; Hypert | 1992 |
The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension.
Topics: Atenolol; Black People; Body Mass Index; Chlorthalidone; Combined Modality Therapy; Female; Humans; | 1992 |
The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Body Weight; Cardiovascular Diseases | 1992 |
Commentary on the Trial of Antihypertensive Interventions and Management (TAIM) Study.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Female; Humans; Hype | 1992 |
Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Atenolol; Clonidine; Dermatitis, Contact; Do | 1989 |
3 other studies available for atenolol and Weight Loss
| Article | Year |
|---|---|
Nausea/vomiting · tachycardia · unintentional weight loss · Dx?
Topics: Adult; Antithyroid Agents; Atenolol; Female; Humans; Hyperthyroidism; Methimazole; Nausea; Pulmonary | 2017 |
Malignancy-associated multicentric reticulohistiocytosis.
Topics: Antihypertensive Agents; Antineoplastic Agents; Arthralgia; Atenolol; Combined Modality Therapy; Dru | 2011 |
beta-Adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Atenolol; Body Composition; Fatty Acid | 1994 |